Lawrence (Larry) C. Thompson, PhD. is a Senior Principal Scientist in Analytical Research and Development within BioTherapeutic Pharmaceutical Sciences at Pfizer. He has been with Pfizer for 6+ years and is currently analytical lead on viral & plasmid based immunotherapeutics and gene therapies. He received his PhD in Biochemistry from Vanderbilt University in 2006 for his work with enzymes and their structure/function determination, spent 4 years as a post-doc at the University of Tennessee investigating the binding interactions of serum proteins and then 3 years in small biotech at two different companies as a lead scientist in the development of serum-based cancer diagnostics. His work has generated a number of peer reviewed publications and presentations at scientific conferences as well as internally within Pfizer.